Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Scientists can now create skin with hair by reprogramming cells in wounds.

Moles may stop growing because of cell cooperation, not just because of aging cells.

Early-onset male pattern baldness may indicate higher prostate cancer risk.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Alopecia areata gained more interest on social media than pattern hair loss, with TikTok showing more personal stories and YouTube offering higher quality educational content.

Doctors using Google during patient visits can enhance accuracy and outcomes if done transparently and inclusively.

Finasteride and dutasteride have limited use in feminising therapy and are not recommended for routine use.

Finasteride and dutasteride are not recommended for feminizing therapy due to limited effectiveness and potential risks.

Plucking some hairs can trigger nearby unplucked hairs to grow back more due to a collective response.

The review concluded that better studies are needed to prove if Low-Level Laser Therapy devices for hair growth really work.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Alice Yang's life shows how second-generation Chinese-Americans adapt and balance cultural heritage with Western influences.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Mogamulizumab can cause hair loss and skin rashes.

Aesthetic medicine is focusing more on patient needs and using new technologies, but ethical issues and regulation challenges need attention.

Hair restoration surgeons have a 15% yearly risk of being sued, and while they often win, the process is stressful and costly.

Low-dose finasteride may increase erectile dysfunction risk over time.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

Topical minoxidil and oral finasteride and dutasteride are the most effective treatments for male and female pattern hair loss, but study quality varies.

Ultrasound-based radiomics and radiogenomics can improve ovarian cancer diagnosis and treatment, but need better standardization and AI tools.

Cosmetic dermatology is improving with new technologies but faces ethical and regulatory challenges.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

All extraction methods can produce similar quality fucoidan, but a holistic approach is needed for method selection.

Venture capital significantly boosts innovation and growth in plastic surgery.

New and repurposed treatments are improving outcomes in dermatology.

People with hair loss feel distressed and need better, trustworthy information sources.

The metaverse offers potential for managing hair and nail disorders but faces challenges like technology limits and accessibility.

Enzyme injections can effectively treat epidermoid cysts without surgery.

A certain signaling pathway in mice, when increased, causes hair to gray by depleting the cells that give hair its color.